vs

Side-by-side financial comparison of Healthpeak Properties (DOC) and JBT Marel Corp (JBTM). Click either name above to swap in a different company.

JBT Marel Corp is the larger business by last-quarter revenue ($1.0B vs $719.4M, roughly 1.4× Healthpeak Properties). Healthpeak Properties runs the higher net margin — 73.2% vs 5.3%, a 67.9% gap on every dollar of revenue. On growth, JBT Marel Corp posted the faster year-over-year revenue change (115.6% vs 3.1%). Healthpeak Properties produced more free cash flow last quarter ($357.0M vs $83.5M). Over the past eight quarters, JBT Marel Corp's revenue compounded faster (60.3% CAGR vs 8.9%).

Healthpeak Properties, Inc. is an American real estate investment trust that invests in real estate related to the healthcare industry including senior housing, life science, and medical offices. It was organized in 2007 in Maryland and headquartered in Denver, Colorado with offices in Irvine, Nashville and San Francisco. As of December 31, 2019, the company owned interests in 617 properties.

JBT Marel Corporation, formerly known as JBT Corporation, or John Bean Technologies Corporation, is a food processing machinery and automated vehicle company. The company was incorporated in 2008 when FMC Technologies divested its non-energy businesses. The company is based in Chicago, Illinois and traces its history back to a company founded in 1884 by John Bean, an orchardist in Los Gatos, California.

DOC vs JBTM — Head-to-Head

Bigger by revenue
JBTM
JBTM
1.4× larger
JBTM
$1.0B
$719.4M
DOC
Growing faster (revenue YoY)
JBTM
JBTM
+112.5% gap
JBTM
115.6%
3.1%
DOC
Higher net margin
DOC
DOC
67.9% more per $
DOC
73.2%
5.3%
JBTM
More free cash flow
DOC
DOC
$273.5M more FCF
DOC
$357.0M
$83.5M
JBTM
Faster 2-yr revenue CAGR
JBTM
JBTM
Annualised
JBTM
60.3%
8.9%
DOC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DOC
DOC
JBTM
JBTM
Revenue
$719.4M
$1.0B
Net Profit
$114.0M
$53.1M
Gross Margin
34.5%
Operating Margin
17.4%
7.2%
Net Margin
73.2%
5.3%
Revenue YoY
3.1%
115.6%
Net Profit YoY
2406.4%
858.6%
EPS (diluted)
$0.16
$1.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DOC
DOC
JBTM
JBTM
Q4 25
$719.4M
$1.0B
Q3 25
$705.9M
$1.0B
Q2 25
$694.3M
$934.8M
Q1 25
$702.9M
$854.1M
Q4 24
$698.0M
$467.6M
Q3 24
$700.4M
$453.8M
Q2 24
$695.5M
$402.3M
Q1 24
$606.6M
$392.3M
Net Profit
DOC
DOC
JBTM
JBTM
Q4 25
$114.0M
$53.1M
Q3 25
$-117.1M
$66.0M
Q2 25
$31.7M
$3.4M
Q1 25
$42.8M
$-173.0M
Q4 24
$4.5M
$-7.0M
Q3 24
$85.9M
$38.9M
Q2 24
$146.0M
$30.7M
Q1 24
$6.7M
$22.8M
Gross Margin
DOC
DOC
JBTM
JBTM
Q4 25
34.5%
Q3 25
58.6%
35.9%
Q2 25
60.2%
35.8%
Q1 25
61.1%
34.2%
Q4 24
60.3%
38.4%
Q3 24
60.0%
36.1%
Q2 24
60.6%
35.6%
Q1 24
59.8%
35.8%
Operating Margin
DOC
DOC
JBTM
JBTM
Q4 25
17.4%
7.2%
Q3 25
9.2%
10.2%
Q2 25
5.7%
5.2%
Q1 25
7.7%
-3.9%
Q4 24
-2.2%
3.4%
Q3 24
14.1%
10.3%
Q2 24
22.3%
6.7%
Q1 24
3.7%
7.4%
Net Margin
DOC
DOC
JBTM
JBTM
Q4 25
73.2%
5.3%
Q3 25
-16.6%
6.6%
Q2 25
4.6%
0.4%
Q1 25
6.1%
-20.3%
Q4 24
0.7%
-1.5%
Q3 24
12.3%
8.6%
Q2 24
21.0%
7.6%
Q1 24
1.1%
5.8%
EPS (diluted)
DOC
DOC
JBTM
JBTM
Q4 25
$0.16
$1.04
Q3 25
$-0.17
$1.26
Q2 25
$0.05
$0.07
Q1 25
$0.06
$-3.35
Q4 24
$0.02
$-0.22
Q3 24
$0.12
$1.21
Q2 24
$0.21
$0.95
Q1 24
$0.01
$0.71

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DOC
DOC
JBTM
JBTM
Cash + ST InvestmentsLiquidity on hand
$467.5M
$167.9M
Total DebtLower is stronger
$9.8B
$1.5B
Stockholders' EquityBook value
$7.5B
$4.5B
Total Assets
$20.3B
$8.2B
Debt / EquityLower = less leverage
1.31×
0.33×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DOC
DOC
JBTM
JBTM
Q4 25
$467.5M
$167.9M
Q3 25
$91.0M
Q2 25
$89.4M
Q1 25
$70.6M
Q4 24
$119.8M
$1.2B
Q3 24
$180.4M
Q2 24
$106.9M
Q1 24
$101.8M
Total Debt
DOC
DOC
JBTM
JBTM
Q4 25
$9.8B
$1.5B
Q3 25
$9.1B
$1.5B
Q2 25
$9.0B
$1.5B
Q1 25
$8.9B
$2.0B
Q4 24
$8.7B
$1.3B
Q3 24
$8.6B
$648.3M
Q2 24
$8.6B
$647.7M
Q1 24
$8.8B
$647.0M
Stockholders' Equity
DOC
DOC
JBTM
JBTM
Q4 25
$7.5B
$4.5B
Q3 25
$7.6B
$4.4B
Q2 25
$7.9B
$4.4B
Q1 25
$8.2B
$4.1B
Q4 24
$8.4B
$1.5B
Q3 24
$8.6B
$1.6B
Q2 24
$8.8B
$1.5B
Q1 24
$8.9B
$1.5B
Total Assets
DOC
DOC
JBTM
JBTM
Q4 25
$20.3B
$8.2B
Q3 25
$19.6B
$8.2B
Q2 25
$19.8B
$8.3B
Q1 25
$19.8B
$8.0B
Q4 24
$19.9B
$3.4B
Q3 24
$20.0B
$2.8B
Q2 24
$20.2B
$2.7B
Q1 24
$20.5B
$2.7B
Debt / Equity
DOC
DOC
JBTM
JBTM
Q4 25
1.31×
0.33×
Q3 25
1.20×
0.34×
Q2 25
1.14×
0.35×
Q1 25
1.08×
0.48×
Q4 24
1.04×
0.81×
Q3 24
1.00×
0.41×
Q2 24
0.98×
0.43×
Q1 24
0.99×
0.43×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DOC
DOC
JBTM
JBTM
Operating Cash FlowLast quarter
$1.3B
$117.4M
Free Cash FlowOCF − Capex
$357.0M
$83.5M
FCF MarginFCF / Revenue
49.6%
8.3%
Capex IntensityCapex / Revenue
124.4%
3.4%
Cash ConversionOCF / Net Profit
10.99×
2.21×
TTM Free Cash FlowTrailing 4 quarters
$238.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DOC
DOC
JBTM
JBTM
Q4 25
$1.3B
$117.4M
Q3 25
$315.0M
$87.7M
Q2 25
$363.5M
$102.2M
Q1 25
$279.4M
$34.4M
Q4 24
$1.1B
$128.7M
Q3 24
$318.2M
$71.9M
Q2 24
$316.2M
$21.6M
Q1 24
$152.6M
$10.4M
Free Cash Flow
DOC
DOC
JBTM
JBTM
Q4 25
$357.0M
$83.5M
Q3 25
$56.5M
Q2 25
$83.7M
Q1 25
$14.4M
Q4 24
$333.7M
$118.7M
Q3 24
$65.0M
Q2 24
$11.1M
Q1 24
$-100.0K
FCF Margin
DOC
DOC
JBTM
JBTM
Q4 25
49.6%
8.3%
Q3 25
5.6%
Q2 25
9.0%
Q1 25
1.7%
Q4 24
47.8%
25.4%
Q3 24
14.3%
Q2 24
2.8%
Q1 24
-0.0%
Capex Intensity
DOC
DOC
JBTM
JBTM
Q4 25
124.4%
3.4%
Q3 25
3.1%
Q2 25
2.0%
Q1 25
2.3%
Q4 24
105.6%
2.1%
Q3 24
1.5%
Q2 24
2.6%
Q1 24
2.7%
Cash Conversion
DOC
DOC
JBTM
JBTM
Q4 25
10.99×
2.21×
Q3 25
1.33×
Q2 25
11.48×
30.06×
Q1 25
6.52×
Q4 24
235.43×
Q3 24
3.71×
1.85×
Q2 24
2.17×
0.70×
Q1 24
22.85×
0.46×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons